Form 8-K - Current report:
SEC Accession No. 0000849146-24-000146
Filing Date
2024-11-19
Accepted
2024-11-19 17:12:02
Documents
14
Period of Report
2024-11-18
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lfvn-20241118.htm   iXBRL 8-K 31126
2 EX-3.1 lfvn-certificateofterminat.htm EX-3.1 15923
  Complete submission text file 0000849146-24-000146.txt   181652

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20241118.xsd EX-101.SCH 1807
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20241118_lab.xml EX-101.LAB 23707
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20241118_pre.xml EX-101.PRE 13601
16 EXTRACTED XBRL INSTANCE DOCUMENT lfvn-20241118_htm.xml XML 2898
Mailing Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043
Business Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

EIN.: 900224471 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35647 | Film No.: 241477235
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)